October 2017

CareDx Completes $20 Million Public Offering

United States - Minnesota

Craig-Hallum Capital Group, acting as the sole book-running manager, and H.C. Wainwright & Co., acting as co-manager, completed an upsized $20.0 million public offering of common stock for CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. The offering closed on October 10, 2017. Faegre Baker Daniels represented the underwriters in the transaction.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。